CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the updated portfolio of Voluson™ ...
1don MSNOpinion
DeWitt: Does health care have to be like this?
I need to do it because I, like millions of other women, am a breast cancer survivor. The exams are uncomfortable and a ...
The latest generation of breast cancer screening equipment has entered the Savannah market, and it boils down to a matter of black and white. Would you rather look for something tiny, dangerous and ...
Integrated artificial intelligence (AI) and advanced tools improve image quality and exam speed to help providers make accurate diagnoses and tailor precision care for women Latest Voluson Signature ...
GE HealthCare has raised the curtain on two ultrasound systems equipped with artificial intelligence programs designed to assist in diagnosing conditions in women’s health, including obstetric exams.
Pregnant women covered by Medicaid are less likely to get an ultrasound exam that can diagnose heart defects in a fetus, a new study finds. "The 20-week ultrasound is hugely important in detecting ...
Latest Voluson Expert 22, 20 and 18 ultrasound systems harness artificial intelligence and advanced tools and software for more efficient assessments Voluson Expert Series delivers elevated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback